Viewing Study NCT05101850


Ignite Creation Date: 2025-12-24 @ 5:03 PM
Ignite Modification Date: 2025-12-27 @ 11:42 PM
Study NCT ID: NCT05101850
Status: COMPLETED
Last Update Posted: 2022-05-26
First Post: 2021-09-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Metabolic Cost of IMT
Sponsor:
Organization:

Raw JSON

{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE', 'observationalModel': 'CASE_CROSSOVER'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 40}, 'patientRegistry': False}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2021-10-18', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2022-05', 'completionDateStruct': {'date': '2022-05-16', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2022-05-25', 'studyFirstSubmitDate': '2021-09-30', 'studyFirstSubmitQcDate': '2021-10-21', 'lastUpdatePostDateStruct': {'date': '2022-05-26', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2021-11-01', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2022-05-16', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Recruitment', 'timeFrame': 'Through study completion, 9 months', 'description': 'The number of patients recruited to the trial compared to the number of eligible patients within the recruitment window'}, {'measure': 'Adherence to IMT', 'timeFrame': 'Throughout the trial period of each participant whilst enrolled i study', 'description': 'The adherence to the prescribed IMT protocol, including reasons for non-adherence'}, {'measure': 'Prevalence of technical issues with relation to the Beacon Caresystem', 'timeFrame': 'Through study completion, 9 months', 'description': 'Defined as inability to calibrate before intervention, missing data during interventions, inability to analyse data from interventions.'}], 'secondaryOutcomes': [{'measure': 'Assessment of VO2 and VCO2 in ICU patients at rest', 'timeFrame': '60 minutes before physical rehabilitation or inspiratory muscle training', 'description': 'Measured in ml/kg/min calculated as the mean VO2 and VCO2 during 60 consecutive minutes where there was a \\<10% variation in VO2 and VCO2 at rest'}, {'measure': 'Comparison of VO2 and VCO2 during IMT at different percentages of PImax within and between patients', 'timeFrame': 'During inspiratory muscle training and for 30 minutes after inspiratory muscle training has ceased', 'description': 'Measured in ml/kg/min for the total IMT session (2 sets of 6 breaths) and 30 minutes after the intervention (analysis of recovery time to baseline)'}, {'measure': 'Prevalence of low PImax in patients receiving mechanical ventilation and PImax change during course of their admission', 'timeFrame': 'Day 0 (baseline) and every 5 days whilst the participant is enrolled in the study', 'description': 'Measured in cmH20 at baseline and every five days'}, {'measure': 'Comparison of VO2 and VCO2 during physical rehabilitation in patients receiving mechanical ventilation', 'timeFrame': 'During physical rehabilitation and for 30 minutes after physical rehabilitation has ceased', 'description': 'Measured in ml/kg/min 30 minutes before the intervention, total VO2 and VCO2 during the intervention and 30 minutes after the intervention'}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'conditions': ['Mechanical Ventilation Complication']}, 'referencesModule': {'references': [{'pmid': '40187744', 'type': 'DERIVED', 'citation': 'Jenkins TO, Karbing DS, Rees SE, Poulsen MK, Patel BV, Polkey MI, MacBean V. Metabolic cost of physical rehabilitation in mechanically ventilated patients in critical care: an observational study. BMJ Open Respir Res. 2025 Apr 5;12(1):e002878. doi: 10.1136/bmjresp-2024-002878.'}, {'pmid': '37415048', 'type': 'DERIVED', 'citation': 'Jenkins TO, MacBean V, Poulsen MK, Karbing DS, Rees SE, Patel BV, Polkey MI. The metabolic cost of inspiratory muscle training in mechanically ventilated patients in critical care. Intensive Care Med Exp. 2023 Jul 7;11(1):41. doi: 10.1186/s40635-023-00522-6.'}]}, 'descriptionModule': {'briefSummary': 'Mechanical ventilation is a life-saving intervention used worldwide. Despite this, critically ill patients who undergo mechanical ventilation commonly develop muscle weakness; this includes limb muscle weakness and diaphragmatic weakness.\n\nPhysiotherapy interventions on critically ill patients include; mobilisation to improve limb muscle strength and function, and inspiratory muscle training which aims to target the diaphragm and accessory inspiratory muscles with the goal of improving endurance and strength. Whilst these interventions are standard practice in intensive care, little is known about the physiological load imposed on patients.\n\nThe purpose of this study is to assess the feasibility of using indirect calorimetry (measured using the Beacon Caresystem) to measure the metabolic cost (oxygen consumption \\[VO2\\] and carbon dioxide production \\[VCO2\\]) of inspiratory muscle training and physical rehabilitation in mechanically ventilated intensive care patients.', 'detailedDescription': "This is an initial cross-sectional study using a non-randomised convenience sample. Patients will be studied during either rehabilitation or Inspiratory Muscle Training.\n\nAll participants will have Maximal Inspiratory Pressure (PImax) measured every 5 days. Baseline measurements of VO2 and VCO2 at rest on their baseline ventilation will be measured using the Beacon Caresystem for 1 hour before Inspiratory Muscle Training or physical rehabilitation is initiated.\n\nInspiratory muscle training will will performed using a resistive device (Philips Respironics ® Threshold PEP device) which is inserted into the participants ventilator tubing 30 minutes before starting inspiratory muscle training. At this point, the device will be set to its lowest setting; the resistance will be overcome by support delivered through the ventilator meaning no additional effort for the participant.\n\nThe patient will then perform 12 breaths of inspiratory muscle training at 4cmH20, and at 30%, 50% and 80% PImax with a 30 second rest every 6 breaths and a 10-20 minute rest every 12 breaths\n\nInspiratory muscle training will normally occur five days per a week. The Beacon Caresystem will be connected for analysis up to 2 days per week.\n\nParticipants will receive usual physiotherapy exercise. These will be prescribed by the patient's physiotherapist and may include assisted mobilisation and / or upper and lower limb exercises to help strengthen muscles. Exercises performed will be categorised for analysis in the study according to a scale called the intensive care mobility scale.\n\nWhen physical rehabilitation begins (i.e when the patient starts to move with the physiotherapist); a time stamp will be activated on the Beacon Caresystem. When physical rehabilitation has ended the time stamp will be deactivated.\n\nImmediately after exercise the patient will be asked to rate their exertion using a simple scale designed to measure physical effort, called the BORG rating scale of perceived exertion.\n\nPhysical rehabilitation will normally occur six days per a week. The Beacon Caresystem will be connected for analysis up to 4 days per week."}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'Mechanically ventilated patients', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Patient invasively ventilated for ≥ 72 hours\n* Have an endotracheal tube or tracheostomy in situ\n* Respiratory rate of ≤ 35 breaths/min\n* Fraction Inspired Oxygen (Fi02) ≤ 0.50\n* Co-operative and able to participate in physical rehabilitation and inspiratory muscle training\n* Age ≥ 18 years\n* Patient consent or, in the case that the patient is unable, advice from the next of kin and acceptance of oral and written information describing the study.\n\nExclusion Criteria:\n\n* Undrained pneumothorax/pneumomediastinum\n* The absence of an arterial catheter for blood sampling at study start\n* Unlikely to survive\n* Pregnancy\n* Consultant discretion that patient is not appropriate'}, 'identificationModule': {'nctId': 'NCT05101850', 'briefTitle': 'Metabolic Cost of IMT', 'organization': {'class': 'OTHER', 'fullName': 'Royal Brompton & Harefield NHS Foundation Trust'}, 'officialTitle': 'Measurement of the Metabolic Cost of Inspiratory Muscle Training and Physical Rehabilitation in Mechanically Ventilated Patients; a Feasibility Study', 'orgStudyIdInfo': {'id': '298839'}}, 'contactsLocationsModule': {'locations': [{'zip': 'SW6 3NP', 'city': 'London', 'country': 'United Kingdom', 'facility': 'The Royal Brompton and Harefield Hospitals', 'geoPoint': {'lat': 51.50853, 'lon': -0.12574}}], 'overallOfficials': [{'name': 'Micheal Polkey, PhD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': "Guy's and St Thomas' NHS Foundation Trust"}]}, 'ipdSharingStatementModule': {'ipdSharing': 'NO'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Royal Brompton & Harefield NHS Foundation Trust', 'class': 'OTHER'}, 'collaborators': [{'name': 'Aalborg University', 'class': 'OTHER'}], 'responsibleParty': {'type': 'SPONSOR'}}}}